Azetidinic amino acids: Stereocontrolled synthesis and pharmacological characterization as ligands for glutamate receptors and transporters

Organic and Biomolecular Chemistry

Volumn 3, Issue 21, 2005, Pages 3926-3936

  Bräuner Osborne, Hans ^b   Bunch, Lennart ^b   Chopin, Nathalie ^a   Couty, François ^a   Evano, Gwilherm ^a   Jensen, Anders A ^b   Kusk, Mie ^b   Nielsen, Birgitte ^b   Rabasso, Nicolas ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZETIDINIC AMINO ACIDS; ENENTIOMERICALLY PURE; IONOTROPIC GLU RECEPTORS; MEMBRANE POTENTIAL ASSAY;

ASSAYS; ENZYME INHIBITION; ISOMERS; MOLECULAR STRUCTURE; PHARMACODYNAMICS; PROTEINS; SYNTHESIS (CHEMICAL); THERMODYNAMICS;

AMINO ACIDS;

AMINO ACID; AZETIDINE DERIVATIVE; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; LIGAND; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4;

ANIMAL; ARTICLE; CYCLIZATION; HUMAN; METABOLISM; PROTEIN BINDING; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

AMINO ACID TRANSPORT SYSTEM X-AG; AMINO ACIDS; ANIMALS; AZETIDINES; CYCLIZATION; HUMANS; LIGANDS; PROTEIN BINDING; RECEPTORS, GLUTAMATE; RECEPTORS, METABOTROPIC GLUTAMATE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 27844533939     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b509514j     Document Type: Article

References (39)

1. P. A. Hart and D. H. Rich, in The Practice of Medicinal Chemistry, ed. Camille Georges Wermuth, Academic Press, 3rd edn., 2000.
2. K.-H. Park and M. J. Kurth, Tetrahedron, 2002, 58, 8629-8659.
3. E. Lorthiois, I. Marek and J.-F. Normant, Tetrahedron Lett., 1997, 38, 89-92.
4. For recent examples, see: (a) P. Karoyan, J. Quancard, J. Vaissermann and G. Chassaing, J. Org. Chem., 2003, 68, 2256-2265;
5. (b) J. Quancard, A. Labonne, Y. Jacquot, G. Chassaing, S. Lavielle and P. Karoyan, J. Org. Chem., 2004, 69, 7940-7948.
6. F. Couty, Amino Acids, 1999, 16, 397-420.
7. L. Bunch, T. Liljefors, J. R. Greenwood, K. Frydenvang, H. Bräuner-Osborne, P. Krogsgaard-Larsen and U. Madsen, J. Org. Chem., 2002, 68, 1489-1495.
8. (a) A. P. Kozikowski, W. Tückmantel, I. J. Reynolds and J. T. Wrobleski, J. Med. Chem., 1990, 33, 1561-1571;
9. (b) S. Hanessian, M. J. Fu, J.-L. Chiara and R. Di Fabio, Tetrahedron Lett., 1993, 34, 4157-4160;
10. (c) S. Hanessian, N. Bernstein, R.-Y. Yang and R. Maguire, Bioorg. Med. Chem. Lett., 1999, 9, 1437-1442;
11. (d) F. Couty, G. Evano and N. Rabasso, Tetrahedron: Asymmetry, 2003, 14, 2407-2412;
12. (e) J. Jiang, H. Shah and R. DeVita, J. Org. Lett., 2003, 5, 4101-4103;
13. (f) G. Gerona-Navarro, M. Angeles Bonache, M. Alías, M. J. Pérez de Vega, T. García-López, M. Pilar López, C. Cativiela and R. González-Muñiz, Tetrahedron Lett., 2004, 45, 2193-2196.
14. F. Couty, G. Evano and D. Prim, Mini-Rev. Org. Chem., 2004, 1, 133-148.
15. For a preliminary communication, see: A. Carlin-Sinclair, F. Couty and N. Rabasso, Synlett, 2003, 726-729.
16. A. P. Kozikowski, Y. Liao, W. Tückmantel, S. M. Wang, S. Pshenichkin, A. Surin, C. Thomsen and J. T. Wroblewski, Bioorg. Med. Chem. Lett., 1996, 6, 2559-2564.
17. H. Bräuner-Osborne, J. Egebjerg, E. O. Nielsen, U. Madsen and P. Krogsgaard-Larsen, J. Med. Chem., 2000, 43, 2609-2645.
18. R. Dingledine, K. Borges, D. Bowie and S. F. Traynelis, Pharmacol. Rev., 1999, 51, 7-61.
19. G. Campiani, C. Fattorusso, M. De Angelis, B. Catalanotti, S. Butini, R. Fattorusso, I. Fiorini, V. Nacci and E. Novellino, Curr. Pharm. Des., 2003, 9, 599-625.
20. R. P. Seal and S. G. Amara, Annu. Rev. Pharmacol. Toxicol., 1999, 39, 431-456.
21. C. Agami, F. Couty and G. Evano, Tetrahedron: Asymmetry, 2002, 13, 297-303.
22. R for 17 was 23.85 min and 22.00 min for ent-17.
23. To the best of our knowledge, intramolecular Michael additions leading to four-membered rings were not previously reported. Few intramolecular Michael additions involving metallated amino nitrile have been reported. For a recent example leading to a pyrrolidine ring, see: S. Yokoshima, H. Tokuyama and T. Fukuyama, Angew. Chem., 2000, 112, 4239-4241.
24. -3. The intensity data were measured on an Enraf-Nonius CAD4 diffractometer (Mo radiation). There were 1988 independent reflections of which 1118 were considered observed. Final discrepancy indices were R = 0.0757 and wR = 0.0880. Crystallographic data have been deposited (number 199691) at the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK.
25. W. C. Still and C. Gennari, Tetrahedron Lett., 1983, 24, 4405-4409.
26. A. Hogner, J. S. Kastrup, R. Jin, T. Liljefors, M. L. Mayer, J. Egebjerg, I. K. Larsen and E. Gouaux, J. Mol. Biol., 2002, 322, 93-109.
27. N. Kunishima, Y. Shimada, Y. Tsuji, T. Sato, M. Yamamoto, T. Kumasaka, S. Nakanishi, H. Jingami and K. Morikawa, Nature, 2000, 407, 971-977.
28. S. Alaux, M. Kusk, E. Sagot, J. Bolte, A. A. Jensen, H. Bräuner-Osborne, T. Gefflaut and L. Bunch, J. Med. Chem., 2005, in press.
29. T. Mennini, E. Fumagalli, M. Gobbi, C. Fattorusso, B. Catalanotti and G. Campiani, Eur. J. Pharmacol., 2003, 479, 291-296.
30. G. Campiani, M. De Angelis, S. Armaroli, C. Fattorusso, B. Catalanotti, A. Ramunno, V. Nacci, E. Novellino, C. Grewer, D. Ionescu, T. Rauen, R. Griffiths, C. Sinclair, E. Fumagalli and T. Mennini, J. Med. Chem., 2001, 44, 2507-2510.
31. H. P. Koch, M. P. Kavanaugh, C. S. Esslinger, N. Zerangue, J. M. Humphrey, S. G. Amara, A. R. Chamberlin and R. J. Bridges, Mol. Pharmacol., 1999, 56, 1095-1104.
32. C. L. Willis, D. L. Dauenhauer, J. M. Humphrey, A. R. Chamberlin, A. L. Buller, D. T. Monaghan and R. J. Bridges, Toxicol. Appl. Pharmacol., 1997, 144, 45-55.
33. R. W. Ransom and N. L. Stec, J. Neurochem., 1988, 51, 830-836.
34. T. Honore and M. Nielsen, Neurosci. Lett., 1985, 54, 27-32.
35. D. J. Braitman and J. T. Coyle, Neuropharmacology, 1987, 26, 1247-1251.
36. M. A. Sills, G. Fagg, M. Pozza, C. Angst, D. E. Brundish, S. D. Hurt, E. J. Wilusz and M. Williams, Eur. J. Pharmacol., 1991, 192, 19-24.
37. M. B. Hermit, J. R. Greenwood, B. Nielsen, L. Bunch, C. G. Jorgensen, H. T. Vestergaard, T. B. Stensbol, C. Sanchez, P. Krogsgaard-Larsen, U. Madsen and H. Bräuner-Osborne, Eur. J. Pharmacol., 2004, 486, 241-250.
38. A. A. Jensen and H. Bräuner-Osborne, Biochem. Pharmacol., 2004, 67, 2115-2127.
39. Y. C. Cheng and W. H. Prusoff, Biochem. Pharmacol., 1973, 22, 3099-3108.